Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting - PubMed (original) (raw)

Clinical Trial

Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting

Andrea Rubboli et al. J Interv Cardiol. 2009 Aug.

Free article

Abstract

Purpose: In patients on oral anticoagulation (OAC) undergoing coronary stenting (PCI-S), procedural management and in-hospital outcome have never been specifically and prospectively investigated. Also, the contribution of early bleeding to the relevant hemorrhagic rate reported at follow-up with triple therapy of OAC, aspirin, and clopidogrel is largely unknown.

Methods: Consecutive patients with indication for OAC undergoing PCI-S at 5 centers were enrolled and prospectively evaluated.

Results: Out of 3410 patients undergoing PCI-S in the study period, indication for OAC was present in 4.8%. Femoral approach and bare metal stents were the most frequently used. During PCI-S, OAC was continued in about 30% of patients, whereas in about 20% heparin bridging was carried out. Glycoprotein IIb/IIIa inhibitors were rarely used (11%), whereas a standard bolus of unfractionated heparin was given in 93% of cases. Major adverse cardiovascular events (MACE) occurred in 4.8% of patients and major bleeding in 4.3%. No predictors of MACE or bleeding were identified, although the femoral approach was of borderline significance for major bleeding (OR 4.6, 95% CI 1.0-20.8; P = 0.05). A history of previous hemorrhage (OR 5.3, 95% CI 1.6-18.1; P = 0.007) predicted Carbofilm-coated stent implantation.

Conclusions: A limited, albeit clinically relevant, proportion of patients undergoing PCI-S has indication for OAC. Procedural management appears not substantially different from that of common patients. In-hospital major bleeding is relevant and should be taken into account when evaluating the overall hemorrhagic rate at a medium- to long-term follow-up.

PubMed Disclaimer

Cited by

Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.
Martinez-Sanchez J, Castrillo L, Jerez D, Torramade-Moix S, Palomo M, Mendieta G, Zafar MU, Moreno-Castaño AB, Sanchez P, Badimon JJ, Diaz-Ricart M, Escolar G, Roqué M. Martinez-Sanchez J, et al. Sci Rep. 2023 Dec 27;13(1):22969. doi: 10.1038/s41598-023-50347-2. Sci Rep. 2023. PMID: 38151494 Free PMC article.
The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).
Wang Y, Wu D, Ma J, Liu X, Zhang H, So CY, Lam YY, Wang B, Wang J, Zhang H, Wang M, Song G, Wu Y. Wang Y, et al. Am J Cardiovasc Dis. 2021 Oct 25;11(5):679-687. eCollection 2021. Am J Cardiovasc Dis. 2021. PMID: 34849300 Free PMC article.
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease.
Moustafa A, Ruzieh M, Eltahawy E, Karim S. Moustafa A, et al. Avicenna J Med. 2019 Oct 3;9(4):123-128. doi: 10.4103/ajm.AJM_73_19. eCollection 2019 Oct-Dec. Avicenna J Med. 2019. PMID: 31903386 Free PMC article. Review.
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study.
Park J, Choi EK, Han KD, Choi YJ, Lee E, Choe W, Lee SR, Cha MJ, Lim WH, Kang J, Park KW, Oh S, Lip GYH. Park J, et al. PLoS One. 2019 Jan 15;14(1):e0209593. doi: 10.1371/journal.pone.0209593. eCollection 2019. PLoS One. 2019. PMID: 30645601 Free PMC article.
Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy.
Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH, Yeh RW, Secemsky EA. Vidula MK, et al. PLoS One. 2018 Oct 31;13(10):e0205457. doi: 10.1371/journal.pone.0205457. eCollection 2018. PLoS One. 2018. PMID: 30379868 Free PMC article.

Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting - PubMed (original) (raw)